Previous 10 | Next 10 |
home / stock / fsddf / fsddf news
FSD Pharma ( OTCQB:FSDDF ) has finalized the acquisition of Prismic Pharmaceuticals' all of the issued and outstanding common and preferred shares valued at $17.5M. More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...
FSD Pharma ( OTCQB:FSDDF ) has finalized the acquisition of Prismic Pharmaceuticals' all of the issued and outstanding common and preferred shares valued at $17.5M. More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...
FSD acquires platform company to advance R&D of targeted application of micro-Palmitoylethanolamide impacting the human endocannabinoid system FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceutica...
FSD acquires platform company to advance R&D of targeted application of micro-Palmitoylethanolamide impacting the human endocannabinoid system FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceutica...
-Full license allows FSD to deliver cannabis to medicinal use markets- FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. (“FV Pharma”) has received it...
Seattle, Washington--(Newsfile Corp. - June 14, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company has b...
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), today announced the appointment of James A. Datin and Robert J. Ciaruffoli, CPA to the Company’s Board of Directors. “It is an honor to welcome Jim Datin ...
FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman...
FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board Canada NewsWire TORONTO, June 6, 2019 – Ziva Cooper, Ph.D. and Mallory Loflin, Ph.D. become latest members of the renowned group of FSD Scientific Advisors ...
Seattle, Washington--(Newsfile Corp. - June 4, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company may b...
News, Short Squeeze, Breakout and More Instantly...
FSD Pharma Inc - Class B Company Name:
FSDDF Stock Symbol:
OTCMKTS Market:
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors Canada NewsWire TORONTO, June 9, 2020 TORONTO , June 9, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the "Company") announces the cl...
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis Canada NewsWire TORONTO, June 3, 2020 TORONTO , June 3, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: ...
FSD Pharma Monetizes Non-Core Asset with Sale of Partial Equity Stake in Pharmadrug Inc. Canada NewsWire TORONTO, May 21, 2020 - Buyer Holds Option to Purchase Additional Shares - TORONTO , May 21, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA...